Skip to main content
Top

19-04-2024 | Hypoglycemia | Original Article

Beyond HbA1c: Identifying Gaps in Glycemic Control Among Children and Young People with Type 1 Diabetes Using Continuous Glucose Monitoring

Authors: Ambica Tandon, Eshita Bhowmik, Zebish Ali, Sarita Tripathi, Ajitha BK, Preeti Dabadghao, Siddhnath Sudhanshu, Vijayalakshmi Bhatia

Published in: Indian Journal of Pediatrics

Login to get access

Abstract

Objectives

To describe continuous glucose monitoring (CGM) derived glycemic variables, and study their association with HbA1c and socio-economic factors in young people with Type 1 diabetes mellitus (T1DM).

Methods

Ninety-two participants [age 15.7 ± 5.0 y (mean ± SD), HbA1c 8.0 ± 1.5% (mean ± SD)] wore a professional CGM sensor for 14 d.

Results

Median (IQR) time in range (TIR) was 41 (18)%. Participants spent 41 ± 20% of their day in hyperglycemia (>180 mg/dl), and 14 (13)% in hypoglycemia (<70 mg/dl). High glycemic variability (percent CV >36%) was seen in 92% participants. Older age at diagnosis was associated with higher TIR (β = 0.267, p = 0.01), lower time above range (TAR) (β = -0.352, p <0.001), but higher time below range (TBR) (β = 0.274, p = 0.006). The use of NPH vs. glargine basal insulin was associated with higher TBR (β = -0.262, p = 0.009) but lower TAR (β = 0.202, p = 0.041). HbA1c showed negative correlation with TIR (= -0.449, p <0.001) and TBR (= -0.466, p <0.001) and positive correlation with TAR (r = 0.580, p <0.001) and mean glucose (r = 0.589, p <0.001).

Conclusions

These data demonstrate wide gaps between the recommended vs. real world glycemic variables in patients with T1DM in this region on multiple daily insulin injections. CGM identifies glycemic variability and complements HbA1c in improving glycemic control.
Literature
1.
go back to reference Diabetes Control and Complications Trial Research Group; Nathan DM, Genuth S, Lachin J, et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New Engl J Med. 1993;329:977–86.CrossRef Diabetes Control and Complications Trial Research Group; Nathan DM, Genuth S, Lachin J, et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New Engl J Med. 1993;329:977–86.CrossRef
2.
go back to reference Nevo-Shenker M, Shalitin S. The impact of hypo- and hyperglycemia on cognition and brain development in young children with type 1 diabetes. Horm Res Paediatr. 2021;94:115–23.CrossRefPubMed Nevo-Shenker M, Shalitin S. The impact of hypo- and hyperglycemia on cognition and brain development in young children with type 1 diabetes. Horm Res Paediatr. 2021;94:115–23.CrossRefPubMed
3.
go back to reference Battelino T, Danne T, Bergenstal RM, et al. Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range. Diabetes Care. 2019;42:1593–603.CrossRefPubMedPubMedCentral Battelino T, Danne T, Bergenstal RM, et al. Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range. Diabetes Care. 2019;42:1593–603.CrossRefPubMedPubMedCentral
4.
go back to reference Battelino T, Alexander CM, Amiel SA, et al. Continuous glucose monitoring and metrics for clinical trials: an international consensus statement. Lancet Diabetes Endocrinol. 2023;11:42–57.CrossRefPubMed Battelino T, Alexander CM, Amiel SA, et al. Continuous glucose monitoring and metrics for clinical trials: an international consensus statement. Lancet Diabetes Endocrinol. 2023;11:42–57.CrossRefPubMed
5.
go back to reference Tandon A, Bhowmik E, Ali Z, et al. Basic carbohydrate counting and glycemia in young people with type 1 diabetes in India: a randomized controlled trial. Nutrition. 2024;119:112318.CrossRefPubMed Tandon A, Bhowmik E, Ali Z, et al. Basic carbohydrate counting and glycemia in young people with type 1 diabetes in India: a randomized controlled trial. Nutrition. 2024;119:112318.CrossRefPubMed
7.
go back to reference Biester T, Grimsmann JM, Heidtmann B, et al. Intermittently scanned glucose values for continuous monitoring: cross-sectional analysis of glycemic control and hypoglycemia in 1809 children and adolescents with type 1 diabetes. Diabetes Technol Ther. 2021;23:160–7.CrossRefPubMed Biester T, Grimsmann JM, Heidtmann B, et al. Intermittently scanned glucose values for continuous monitoring: cross-sectional analysis of glycemic control and hypoglycemia in 1809 children and adolescents with type 1 diabetes. Diabetes Technol Ther. 2021;23:160–7.CrossRefPubMed
8.
go back to reference Cherubini V, Bonfanti R, Casertano A, et al. Time in range in children with type 1 diabetes using treatment strategies based on nonautomated insulin delivery systems in the real world. Diabetes Technol Ther. 2020;22:509–15.CrossRefPubMed Cherubini V, Bonfanti R, Casertano A, et al. Time in range in children with type 1 diabetes using treatment strategies based on nonautomated insulin delivery systems in the real world. Diabetes Technol Ther. 2020;22:509–15.CrossRefPubMed
9.
go back to reference Campbell FM, Murphy NP, Stewart C, Biester T, Kordonouri O. Outcomes of using flash glucose monitoring technology by children and young people with type 1 diabetes in a single arm study. Pediatr Diabetes. 2018;19:1294–301.CrossRefPubMed Campbell FM, Murphy NP, Stewart C, Biester T, Kordonouri O. Outcomes of using flash glucose monitoring technology by children and young people with type 1 diabetes in a single arm study. Pediatr Diabetes. 2018;19:1294–301.CrossRefPubMed
10.
go back to reference Laffel LM, Kanapka LG, Beck RW, et al. Effect of continuous glucose monitoring on glycemic control in adolescents and young adults with type 1 diabetes. JAMA. 2020;323:2388.CrossRefPubMedPubMedCentral Laffel LM, Kanapka LG, Beck RW, et al. Effect of continuous glucose monitoring on glycemic control in adolescents and young adults with type 1 diabetes. JAMA. 2020;323:2388.CrossRefPubMedPubMedCentral
11.
go back to reference Karges B, Schwandt A, Heidtmann B, et al. Association of insulin pump therapy vs insulin injection therapy with severe hypoglycemia, ketoacidosis, and glycemic control among children, adolescents, and young adults with type 1 diabetes. JAMA. 2017;318:1358.CrossRefPubMedPubMedCentral Karges B, Schwandt A, Heidtmann B, et al. Association of insulin pump therapy vs insulin injection therapy with severe hypoglycemia, ketoacidosis, and glycemic control among children, adolescents, and young adults with type 1 diabetes. JAMA. 2017;318:1358.CrossRefPubMedPubMedCentral
12.
go back to reference Elhabashy SA, Sakr EM, Salah NY. The efficacy of insulin degludec and insulin glargine over NPH insulin among toddlers and preschoolers with type 1 diabetes using glycemic variability and time in range. Eur J Pediatr. 2023;182:1857–68.CrossRefPubMedPubMedCentral Elhabashy SA, Sakr EM, Salah NY. The efficacy of insulin degludec and insulin glargine over NPH insulin among toddlers and preschoolers with type 1 diabetes using glycemic variability and time in range. Eur J Pediatr. 2023;182:1857–68.CrossRefPubMedPubMedCentral
13.
go back to reference Danne T, Philotheou A, Goldman D, et al. A randomized trial comparing the rate of hypoglycemia-assessed using continuous glucose monitoring-in 125 preschool children with type 1 diabetes treated with insulin glargine or NPH insulin (the PRESCHOOL study). Pediatr Diabetes. 2013;14:593–601.CrossRefPubMed Danne T, Philotheou A, Goldman D, et al. A randomized trial comparing the rate of hypoglycemia-assessed using continuous glucose monitoring-in 125 preschool children with type 1 diabetes treated with insulin glargine or NPH insulin (the PRESCHOOL study). Pediatr Diabetes. 2013;14:593–601.CrossRefPubMed
14.
go back to reference Valenzano M, Cibrario Bertolotti I, Valenzano A, Grassi G. Time in range–A1c hemoglobin relationship in continuous glucose monitoring of type 1 diabetes: a real-world study. BMJ Open Diabetes Res Care. 2021;9:e001045.CrossRefPubMedPubMedCentral Valenzano M, Cibrario Bertolotti I, Valenzano A, Grassi G. Time in range–A1c hemoglobin relationship in continuous glucose monitoring of type 1 diabetes: a real-world study. BMJ Open Diabetes Res Care. 2021;9:e001045.CrossRefPubMedPubMedCentral
15.
go back to reference Helleputte S, De Backer T, Calders P, Pauwels B, Shadid S, Lapauw B. The added and interpretative value of CGM-derived parameters in type 1 diabetes depends on the level of glycemic control. Endocr Pract. 2021;27:44–50.CrossRefPubMed Helleputte S, De Backer T, Calders P, Pauwels B, Shadid S, Lapauw B. The added and interpretative value of CGM-derived parameters in type 1 diabetes depends on the level of glycemic control. Endocr Pract. 2021;27:44–50.CrossRefPubMed
16.
go back to reference Babaya N, Noso S, Hiromine Y, et al. Relationship of continuous glucose monitoring-related metrics with HbA1c and residual β-cell function in Japanese patients with type 1 diabetes. Sci Rep. 2021;11:4006.CrossRefPubMedPubMedCentral Babaya N, Noso S, Hiromine Y, et al. Relationship of continuous glucose monitoring-related metrics with HbA1c and residual β-cell function in Japanese patients with type 1 diabetes. Sci Rep. 2021;11:4006.CrossRefPubMedPubMedCentral
17.
go back to reference Vigersky RA, McMahon C. The relationship of hemoglobin A1c to time-in-range in patients with diabetes. Diabetes Technol Ther. 2019;21:81–5.CrossRefPubMed Vigersky RA, McMahon C. The relationship of hemoglobin A1c to time-in-range in patients with diabetes. Diabetes Technol Ther. 2019;21:81–5.CrossRefPubMed
18.
go back to reference Marsters BL, Boucher SE, Galland BC, et al. Cutaneous adverse events in a randomized controlled trial of flash glucose monitoring among youth with type 1 diabetes mellitus. Pediatr Diabetes. 2020;21:1516–24.CrossRefPubMed Marsters BL, Boucher SE, Galland BC, et al. Cutaneous adverse events in a randomized controlled trial of flash glucose monitoring among youth with type 1 diabetes mellitus. Pediatr Diabetes. 2020;21:1516–24.CrossRefPubMed
Metadata
Title
Beyond HbA1c: Identifying Gaps in Glycemic Control Among Children and Young People with Type 1 Diabetes Using Continuous Glucose Monitoring
Authors
Ambica Tandon
Eshita Bhowmik
Zebish Ali
Sarita Tripathi
Ajitha BK
Preeti Dabadghao
Siddhnath Sudhanshu
Vijayalakshmi Bhatia
Publication date
19-04-2024
Publisher
Springer India
Published in
Indian Journal of Pediatrics
Print ISSN: 0019-5456
Electronic ISSN: 0973-7693
DOI
https://doi.org/10.1007/s12098-024-05112-2